Detalhe da pesquisa
1.
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer.
Breast Cancer Res
; 26(1): 20, 2024 01 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297352
2.
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Cancer
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662502
3.
The Growing Role of Digital Health Tools in the Care of Patients with Cancer: Current Use, Future Opportunities, and Barriers to Effective Implementation.
Curr Oncol Rep
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652424
4.
Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast.
Breast Cancer Res Treat
; 200(2): 217-224, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210429
5.
Patient Satisfaction With a Multisite, Multiregional Remote Patient Monitoring Program for Acute and Chronic Condition Management: Survey-Based Analysis.
J Med Internet Res
; 25: e44528, 2023 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343182
6.
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Breast Cancer Res Treat
; 196(1): 229-237, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045271
7.
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
; 31(1): 1-9, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649577
8.
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Breast Cancer Res Treat
; 188(2): 477-487, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852121
9.
Adaptive Randomization of Neratinib in Early Breast Cancer.
N Engl J Med
; 375(1): 11-22, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406346
10.
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
N Engl J Med
; 375(1): 23-34, 2016 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406347
11.
Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.
Breast Cancer Res Treat
; 168(3): 639-647, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29289986
12.
Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors.
J Natl Compr Canc Netw
; 16(5): 526-534, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29752327
13.
Impact of treatment regimen on acute care use during and after adjuvant chemotherapy for early-stage breast cancer.
Breast Cancer Res Treat
; 164(3): 515-525, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28493045
14.
Clinicopathologic features of breast cancers that develop in women with previous benign breast disease.
Cancer
; 122(3): 378-85, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26512815
15.
Landscape of neoadjuvant therapy for breast cancer.
Ann Surg Oncol
; 22(5): 1408-15, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25727557
16.
Anastrozole dose escalation for optimal estrogen suppression in postmenopausal early-stage breast cancer: A prospective trial.
Clin Cancer Res
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38752717
17.
Data-Driven and Technology-Enabled Trial Innovations Toward Decentralization of Clinical Trials: Opportunities and Considerations.
Mayo Clin Proc
; 98(9): 1404-1421, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661149
18.
Advances in the care of breast cancer survivors.
BMJ
; 382: e071565, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722731
19.
Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
JAMA Netw Open
; 6(2): e2254669, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735254
20.
Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021.
JCO Oncol Pract
; 19(9): 750-758, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335959